2nd Quarter - Amendment

BUCHANAN INGERSOLL & ROONEY PC for AMIVAS, LLC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (No Activity) Jul 20, 2022 — Replaced
2nd Quarter - Amendment (this page) Jul 20, 2022 — Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Homeland Security HOM

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Veterans VET

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.